Panagora Asset Management’s West Pharmaceutical WST Stock Holding History

Panagora Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.99M	Buy	13,888 +12,811	+1,190%	+$3.92M	0.02%	454
2026 Q1	$270K	Sell	1,077 -23,522	-96%	-$5.85M	﹤0.01%	1013
2025 Q4	$6.77M	Buy	24,599 +23,693	+2,615%	+$6.48M	0.02%	340
2025 Q3	$238K	Buy	+906	New	+$220K	﹤0.01%	1034
2025 Q2	–	Sell	-909	Closed	-$204K	–	1223
2025 Q1	$204K	Sell	909 -571	-39%	-$157K	﹤0.01%	1044
2024 Q4	$485K	Sell	1,480 -1,146	-44%	-$361K	﹤0.01%	848
2024 Q3	$788K	Hold	2,626	–	–	﹤0.01%	797
2024 Q2	$865K	Sell	2,626 -1,438	-35%	-$508K	﹤0.01%	766
2024 Q1	$1.61M	Sell	4,064 -132	-3%	-$48.8K	0.01%	646
2023 Q4	$1.48M	Sell	4,196 -763	-15%	-$270K	0.01%	673
2023 Q3	$1.86M	Buy	4,959 +1,583	+47%	+$612K	0.01%	545
2023 Q2	$1.29M	Buy	3,376 +574	+20%	+$205K	0.01%	701
2023 Q1	$971K	Sell	2,802 -1,986	-41%	-$580K	0.01%	853
2022 Q4	$1.13M	Sell	4,788 -276	-5%	-$65.4K	0.01%	841
2022 Q3	$1.25M	Hold	5,064	–	–	0.01%	773
2022 Q2	$1.53M	Hold	5,064	–	–	0.01%	716
2022 Q1	$2.08M	Buy	5,064 +1,133	+29%	+$444K	0.01%	672
2021 Q4	$1.84M	Sell	3,931 -70,694	-95%	-$30.4M	0.01%	674
2021 Q3	$31.7M	Buy	74,625 +70,136	+1,562%	+$29.6M	0.17%	134
2021 Q2	$1.61M	Buy	4,489 +55	+1%	+$18.2K	0.01%	781
2021 Q1	$1.25M	Buy	4,434 +408	+10%	+$117K	0.01%	927
2020 Q4	$1.14M	Sell	4,026 -105,752	-96%	-$29.7M	0.01%	919
2020 Q3	$30.2M	Buy	109,778 +104,935	+2,167%	+$27.8M	0.19%	116
2020 Q2	$1.1M	Buy	4,843 +323	+7%	+$63.5K	0.01%	890
2020 Q1	$688K	Buy	4,520 +3,077	+213%	+$474K	﹤0.01%	987
2019 Q4	$217K	Buy	1,443 +136	+10%	+$19.8K	﹤0.01%	1576
2019 Q3	$185K	Hold	1,307	–	–	﹤0.01%	1649
2019 Q2	$164K	Hold	1,307	–	–	﹤0.01%	1848
2019 Q1	$144K	Hold	1,307	–	–	﹤0.01%	1796
2018 Q4	$128K	Hold	1,307	–	–	﹤0.01%	1756
2018 Q3	$161K	Hold	1,307	–	–	﹤0.01%	1746
2018 Q2	$130K	Hold	1,307	–	–	﹤0.01%	1782
2018 Q1	$115K	Hold	1,307	–	–	﹤0.01%	1823
2017 Q4	$129K	Hold	1,307	–	–	﹤0.01%	1804
2017 Q3	$126K	Hold	1,307	–	–	﹤0.01%	1834
2017 Q2	$124K	Hold	1,307	–	–	﹤0.01%	1812
2017 Q1	$107K	Buy	1,307 +1,030	+372%	+$86.1K	﹤0.01%	1845
2016 Q4	$23K	Hold	277	–	–	﹤0.01%	2197
2016 Q3	$21K	Buy	277 +22	+9%	+$1.75K	﹤0.01%	2254
2016 Q2	$19K	Hold	255	–	–	﹤0.01%	2167
2016 Q1	$18K	Hold	255	–	–	﹤0.01%	2154
2015 Q4	$15K	Sell	255 -558	-69%	-$33.6K	﹤0.01%	2183
2015 Q3	$44K	Sell	813 -1,149	-59%	-$67K	﹤0.01%	2026
2015 Q2	$114K	Sell	1,962 -27,127	-93%	-$1.51M	﹤0.01%	1911
2015 Q1	$1.75M	Sell	29,089 -62,490	-68%	-$3.33M	0.01%	826
2014 Q4	$4.88M	Sell	91,579 -68,168	-43%	-$3.41M	0.02%	477
2014 Q3	$7.15M	Buy	159,747 +85,161	+114%	+$3.62M	0.03%	402
2014 Q2	$3.15M	Buy	74,586 +64,300	+625%	+$2.75M	0.02%	670
2014 Q1	$453K	Sell	10,286 -4,451	-30%	-$210K	﹤0.01%	1454
2013 Q4	$723K	Buy	14,737 +9	+0.1%	+$421	﹤0.01%	1280
2013 Q3	$606K	Sell	14,728 -20,466	-58%	-$781K	﹤0.01%	1294
2013 Q2	$1.24M	Buy	+35,194	New	+$1.16M	0.01%	977

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Panagora Asset Management's WST Position: Q2 2026 in Review

Panagora Asset Management increased its West Pharmaceutical (WST) stake by 1,190% in Q2 2026, buying an estimated $3.92M and bringing the position to 13,888 shares worth $4.99M. The position accounts for 0.02% of the portfolio, ranked #454.

Panagora Asset Management first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.7M in Q3 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Panagora Asset Management held 13,888 shares of West Pharmaceutical worth $4.99M as of Q2 2026.
Panagora Asset Management bought 12,811 West Pharmaceutical shares in Q2 2026, an estimated $3.92M.
West Pharmaceutical made up 0.02% of Panagora Asset Management's portfolio in Q2 2026, its #454 holding.
Panagora Asset Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
Panagora Asset Management's West Pharmaceutical position peaked at $31.7M in Q3 2021.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.